Director, Marketing & Digital Engagement

Director, Marketing & Digital Engagement

It's More Than a Career, It's a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
The Director, Marketing & Digital Engagement leads SCRI's enterprise marketing and digital strategy, driving integrated brand campaigns and overseeing a cohesive digital ecosystem across all channels. This role brings the SCRI brand to life through multi-channel marketing, digital, social, and experiential activation while ensuring consistent digital standards, governance, and user experience across corporate and network sites.
Working closely with cross-functional and executive partners, this leader aligns marketing and digital initiatives with organizational priorities, advances digital innovation, and improves the patient journey and trial discoverability. The director also oversees analytics and performance measurement, translating insights into strategic recommendations that strengthen engagement and business impact, and serves as SCRI's enterprise digital subject matter expert for internal teams and research sites.
Duties include but are not limited to:
Integrated Marketing Campaigns & Brand Activation
Enterprise Digital Strategy & Ownership
Cross-Functional Collaboration & GTM Leadership
Digital Innovation, Best Practices & Patient Journey Optimization
Analytics, Measurement & Optimization
Stakeholder & Network Support
Team Management
Mandatory: The following are mandatory expectations of all SCRI employees.
Practices and adheres to the "Code of Conduct" philosophy and "Mission and Value Statement."
During your employment with SCRI, you will be routinely assigned training requirements. You are expected to complete any training assignments by the due date.
Minimum Qualifications:
Bachelor's Degree required; Master's Degree preferred
7+ years of relevant experience
Knowledge:
Deep knowledge of omni-channel marketing strategy, including digital, social, content, experiential, and paid media.
Strong understanding of enterprise digital ecosystems, including web platforms, UX/UI best practices, accessibility standards, and content governance.
Expertise in modern digital marketing tools and technologies (CMS, CRM, marketing automation, analytics platforms, SEO/GEO optimization, and social media management).
Solid understanding of brand strategy, creative development, and how to translate brand platforms into integrated campaigns and digital experiences.
Knowledge of performance measurement, digital analytics, KPI frameworks, and data-driven optimization.
Familiarity with healthcare, clinical research, or highly regulated environments (preferred but not required).
Skills:
Successful track record as a people leader – Inspires colleagues to excel
Customer focused mindset
Strong Communication & Presentation skills
Executive Presence
Abilities:
Ability to excel in a fast paced, highly matrixed organization.
Strategic mindset
Strong work ethic
Ability to develop and nurture relationships with key executive leadership
This position is hybrid in Nashville, TN.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI's research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.